Document 0933
 DOCN  M9540933
 TI    Bacteriostatic and bactericidal activities of paromomycin against
       Mycobacterium avium complex isolates.
 DT    9504
 AU    Piersimoni C; Bornigia S; De Sio G; Scalise G; Department of Clinical
       Microbiology, General Hospital Umberto I.,; Torrette, Ancona, Italy.
 SO    J Antimicrob Chemother. 1994 Sep;34(3):421-4. Unique Identifier :
       AIDSLINE MED/95130443
 AB    The MICs and MBCs of paromomycin for 32 Mycobacterium avium complex
       (MAC) strains isolated from patients with the acquired immunodeficiency
       syndrome were determined by a radiometric broth dilution method. The
       MICs for the majority of strains were either 8 or 16 mg/L and the MBCs
       were four- to eight-fold higher. Paromomycin merits further evaluation
       as oral prophylaxis against disseminated MAC infection.
 DE    Acquired Immunodeficiency Syndrome/MICROBIOLOGY  Human  Microbial
       Sensitivity Tests  Mycobacterium avium Complex/*DRUG EFFECTS/GROWTH &
       DEVELOPMENT/  ISOLATION & PURIF  Paromomycin/*PHARMACOLOGY  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).